Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05506267 · ClinicalTrials.gov registry record
Development of a Tracheal Sound Sensor
A clinical trial of Respiratory Insufficiency and Opioid Overdose, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05506267: Completed study of Respiratory Insufficiency and Opioid Overdose, sponsored by Thomas Jefferson University.
NCT05506267 is a study of Respiratory Insufficiency and Opioid Overdose that has completed, run by Thomas Jefferson University. The registered enrollment target is 20 participants, below the 749-participant average among 10 other Respiratory Insufficiency trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05506267, a study of Respiratory Insufficiency and Opioid Overdose, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
An observational study will be conducted in 20 hospitalized surgical patients routinely managed with opioids for anesthesia and post-operative pain control. Trachea Sound Sensor measurements and reference respiratory measurements will be recorded and analyzed to develop diagnostic algorithms that produce a risk-index score that detects/predicts progression from mild hypoventilation, to moderate hypoventilation, to severe hypoventilation due to opioids and other medications that cause respiratory depression. Our current Trachea Sound Sensor (TSS) has a wired Sony commercial microphone integrated into a commercial pediatric stethoscope, coupled to the skin surface over the trachea at the sternal notch. The Trachea Sound Sensor will measure and record the sounds of air moving within the proximal trachea during inhalation and exhalation. The microphone signal will be converted into an accurate measurement of the patient's respiratory rate and tidal volume (during inhalation \& exhalation) over time, to determine the minute ventilation trend, breathing patterns, apnea episodes, and degree of snoring (due to partial upper airway obstruction). A commercial respiratory facemask and two pneumotachs (gas flow sensors) will also be used to accurately and continuously measure the patient's respiratory rate and tidal volume (during inhalation \& exhalation) to determine the minute ventilation trend, breathing patterns, and apnea episodes. TSS data and reference respiratory data will be collected prior to surgery with the patient breathing normally (baseline), in the Operating Room (OR) during the induction and maintenance of anesthesia, in the Post Anesthesia Care Unit (PACU), and on the general nursing floors of Thomas Jefferson University Hospital (TJUH). The sounds of air flowing through the proximal trachea will be correlated with the reference breathing measurements using signal processing methods to optimize the measurement accuracy of RR, TV, breathing pattern, apnea
Primary Outcome
The wearable Trachea Sound Sensor (TSS) will measure and analyze the sounds of air flow in the trachea during inhalation and exhalation to calculate respiratory rate (RR). Calibrated pneumotachs attached to a tight fitting face mask and a capnometer will be used to simultaneously measure the patient's RR. TSS measurements and reference respiratory measurements will be analyzed and correlated using a transfer function algorithm to calculate respiratory rate with sufficient accuracy for clinical c
Conditions Studied
Interventions
- DEVICE Trachea Sound Sensor (TSS)
Study Locations (1)
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2022-04-30 |
What the finished NCT05506267 record still lists
NCT05506267 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 749-participant average among 10 other Respiratory Insufficiency trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Respiratory Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Trachea Sound Sensor (TSS) is the first listed.
NCT05506267 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05506267 about?
NCT05506267 is a clinical study titled "Development of a Tracheal Sound Sensor". An observational study will be conducted in 20 hospitalized surgical patients routinely managed with opioids for anesthesia and post-operative pain control. Trachea Sound Sensor measurements and reference respiratory measurements will be recorded and analyzed to develop diagnostic algorithms that pr...
What is the current status of trial NCT05506267?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2020-06-01. Estimated completion is 2022-04-30.
What conditions does trial NCT05506267 study?
This clinical trial studies the following conditions: Respiratory Insufficiency, Opioid Overdose, Hypoventilation.
What interventions are being tested in trial NCT05506267?
The interventions under investigation include: Trachea Sound Sensor (TSS) (DEVICE).
Who is sponsoring clinical trial NCT05506267?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05506267 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05506267's enrollment target sits among peer trials
20 9th of 10 higher than 2 of 10 other Respiratory Insufficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Insufficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Platform of Randomized Adaptive Clinical Trials in Critical Illness
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
-
Combined Respiratory Training in Persons With ALS
RECRUITING · NA
-
Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants
ACTIVE NOT RECRUITING · NA
-
Flow-synchronized Nasal IMV in Preterm Infants
COMPLETED · NA
-
Behavioral Activation-Rehabilitation to Improve Depressive Symptoms & Physical Function After Acute Respiratory Failure
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI